Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Lexeo Therapeutics, Inc. Common Stock | StockGist | StockGist

Companies
LXEO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings LXEOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Lexeo Therapeutics, Inc. Common Stock

Filed Feb 13, 2026

Accepted Feb 12, 2026, 7:00 PM ET

CIK 0001907108

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

0

Reporting Person

Lexeo Therapeutics, Inc.

Person Type

PN

CUSIP: 52886X107

Amendment History

6 filings

SCHEDULE 13G
Original
Jan 30, 20260000102909-26-000183
SCHEDULE 13G/A
Amendment 1
Jan 29, 20260001315863-26-000099
SCHEDULE 13G/A
Amendment 2
Viewing
Feb 13, 20260001231919-26-000153
SCHEDULE 13G/A
Amendment 3
Feb 17, 20260001104659-26-016355
SCHEDULE 13G/A
Amendment 4
Feb 17, 20260001193125-26-052896
SCHEDULE 13G/A
Amendment 5
Latest
Feb 17, 20260001104659-26-016498

Key Facts

Shares Owned

0

Recent Filings

Lexeo Therapeutics, Inc. Common Stock5 days ago

Lexeo Therapeutics, Inc. Common Stock5 days ago

Lexeo Therapeutics, Inc. Common Stock1 months ago

Lexeo Therapeutics, Inc. Common Stock1 months ago

Lexeo Therapeutics, Inc. Common Stock1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice